Trially uses AI to help recruit patients for clinical trials.
Founded in 2023 and based in Kansas City, US, Trially develops a HIPAA-compliant platform that analyzes electronic health record data to help sponsors, CROs and research sites identify and enroll clinical trial candidates. In August 2025, it raised USD 4.7 million in seed funding led by Flyover Capital, with participation from Alpaca, Atria Ventures, Blu Venture Investors, Looking Glass Capital, Redbud VC, The Council and Gaingels. The company plans to develop its platform and expand in Europe and other international markets.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in